http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2692666-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5f220ff41ebe4c7f2e7da8ec7e7e9dca |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-007 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B8-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B8-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007 |
| filingDate | 2019-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21d5adf4d344a34fd73b9d40b34be13e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_97d078b6fc8d47743d7e19e3ab2f2595 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_748d2ccedeb14cee2559902315bc43ab http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5c916e57a3924c8692d9ea653258f03 |
| publicationDate | 2019-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2692666-C1 |
| titleOfInvention | Method for objective assessment of clinical effectiveness of floating opacity of vitreous body by yag-laser vitreolysis |
| abstract | FIELD: medicine. n SUBSTANCE: invention refers to medicine, namely to ophthalmology, radiation diagnostics, and can be used for objective assessment of clinical effectiveness of floating opacity of vitreous body (FOVB) by YAG-laser vitreolysis method. Ultrasonic examination of vitreous body in B-scan mode is performed. At first, prior to YAG-laser vitreolysis, three scans are performed in two mutually perpendicular planes: sagittal and frontal through a localization zone FOVB. Further, each scan is digitally processed in an ImageJ computer program, namely, a central portion of a vitreous body is selected in the form of a circle with diameter of 10 mm. In the same program, in each selected section, a measure is measured – averaged gray value in pixels. Then, the six derived values are used to calculate an average pre-treatment value. One month after YAG-laser vitreolysis the same value is calculated similarly. If re-examination shows decreasing averaged value of gray by more than 10 %, then treatment is considered to be effective; by 5–10 % – treatment is considered ineffective, recommended is additional session of YAG-laser vitreolysis; less than by 5 % – treatment is considered ineffective, vitrectomy is recommended. n EFFECT: method provides higher speed, accuracy, reliability and objectivity of diagnostics of FOVB before and after YAG-laser vitreolysis by measuring averaged gray value in pixels in central area of vitreous body on six scans during digital processing in computer program ImageJ of ultrasonic examination in B-scan mode. n 1 cl, 3 ex |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113057574-A |
| priorityDate | 2019-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 23.